T-cell engagers, especially BiTEs, show promise in treating solid tumors by targeting tumor-associated antigens and redirecting T-cell activity. Tarlatamab, targeting DLL3 in SCLC, demonstrated ...

University of Arizona Cancer Center researchers will study the potential effects of the loss of the Y chromosome in the ...

U of A Comprehensive Cancer Center Director Dr. Dan Theodorescu plans to study loss of Y chromosome biology and investigate ...

In the animal-based studies, a nanoparticle-based vaccine shrunk, cleared and prevented cancer growth, including melanoma.

We’ve all experienced common issues like headaches, vision changes, nausea, stomach pain, and mouth sores. These don’t tend to cause us much worry because they’re usually symptoms of benign issues ...

MIT and Harvard scientists have designed an advanced type of immune cell called a CAR-NK cell that can destroy cancer while ...

Genetic information in cancer cells reveals the strength of cancer–immune interactions in an individual-based stochastic model, which captures explicit interactions between cancer and effector cells.

Chinese researchers have developed a novel method to efficiently engineer natural killer (NK) cells for cancer immunotherapy.

A new cancer treatment combines LED light and tiny tin flakes to neutralize cancer cells while shielding healthy cells and ...

Researchers have cracked the code behind how plants make mitraphylline, a rare cancer-fighting molecule. Their discovery of ...

The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

The company said that its experimental drug, Telomir-1, selectively kills aggressive triple-negative breast cancer cells by ...